Cellular therapies in rheumatic and musculoskeletal diseases
A substantial proportion of patients diagnosed with rheumatologic and musculoskeletal diseases (RMDs) exhibit resistance to conventional therapies or experience recurrent symptoms. These diseases, which include autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, and systemic lupus...
Saved in:
Main Authors: | Pedro Franco-Fuquen, Juana Figueroa-Aguirre, David A. Martínez, Eider F. Moreno-Cortes, Juan E. Garcia-Robledo, Fabio Vargas-Cely, Daniela A. Castro-Martínez, Mustafa Almaini, Januario E. Castro |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | Journal of Translational Autoimmunity |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909024000340 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Burden of associated comorbidities in autoimmune rheumatic diseases in Indian population: An interim report based on the Indian rheumatology association database
by: S Chandrashekara, et al.
Published: (2022-01-01) -
Primer on the Rheumatic Diseases /
Published: (1993) -
Prescribing patterns and safety of biologics in immune-mediated rheumatic diseases: Karnataka biologics cohort study group experience
by: Vineeta Shobha, et al.
Published: (2019-01-01) -
Comparative Analysis of CXCR5 Circulating DNA Methylation Levels in Autoimmune Rheumatic Diseases
by: Yiming Shi, et al.
Published: (2025-01-01) -
The Importance of Monitoring Baseline and Regular Immunoglobulin Levels in Managing Secondary Hypogammaglobulinemia in Rheumatic Diseases: A Case Report and Systematic Review
by: Winnie Wan Yin Yeung
Published: (2024-12-01)